The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding
- PMID: 33559727
- PMCID: PMC7871319
- DOI: 10.1007/s00296-021-04797-4
The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding
Abstract
Objectives: We sought to gain insight into the prevalence of COVID-19 and the impact stringent social distancing (shielding) has had on a large cohort of rheumatology (RD) follow-up patients from a single large UK centre.
Methods: We linked COVID-19-related deaths, screening and infection rates to our RD population (1.2.20-1.5.20) and audited active rheumatology follow-up patients through survey data communicated via a linked mobile phone SMS message. We assessed epidemiology, effect of stringent social distancing (shielding) and quality of life (HRQoL) by Short Form 12 (SF12).
Results: There were 10,387 active follow-up patients, 7911 had linked mobile numbers. 12/10,387 RD patients died from COVID-19 (0.12%); local population 4131/7,415,149 (0.12%). For patients with mobile phones, 1693/7911 (21%) responded and of these, 1605 completed the SF12. Inflammatory arthritis predominated 1174/1693 (69%); 792/1693 (47%) were shielding. Advice on shielding/distancing was followed by 1372/1693(81%). 61/1693 (4%) reported COVID-19 (24/61 shielding); medication distribution was similar in COVID and non-COVID patients. Mental SF12 (MCS) but not physical (PCS) component scores were lower in COVID (60) vs. non-COVID (1545), mean differences: MCS, - 3.3; 95% CI - 5.2 to - 1.4, P < 0.001; PCS, - 0.4; 95% CI, - 2.1 to 1.3). In 1545 COVID-negative patients, those shielding had lower MCS (- 2.1; 95% CI - 2.8 to - 1.4) and PCS (- 3.1, 95% CI - 3.7 to - 2.5), both P < 0.001.
Conclusions: Our full RD cohort had no excess of COVID deaths compared to the general local population. Our survey data suggest that shielding adversely affects both mental and physical health in RD. These data broaden our understanding of shielding, indicating need for further study.
Keywords: COVID-19; Health care delivery; Health service research; Quality improvement; Quality of life indicators; Rheumatic disease.
Conflict of interest statement
The authors declare no competing interests.
Comment in
-
Patient self-sampling: a cornerstone of future rheumatology care?Rheumatol Int. 2021 Jun;41(6):1187-1188. doi: 10.1007/s00296-021-04853-z. Epub 2021 Apr 10. Rheumatol Int. 2021. PMID: 33839886 Free PMC article. No abstract available.
References
-
- EULAR. (2020) Policy statement on COVID-19. Available from: https://www.eular.org/eular_guidance_for_patients_covid19_outbreak.cfm. Accessed 20 May 2020.
-
- British Society for Rheumatology. (2020) COVID-19 (Coronavirus)-update for members. Available from: https://www.rheumatology.org.uk/news-policy/details/covid19-coronavirus-.... Accessed 25 May 2020.
-
- Price E, MacPhie E, Kay L, Lanyon P, Griffiths B, Holroyd C, Abhishek A, Youngstein T, Bailey K, Clinch J, Shaikh M, Rivett A. Identifying rheumatic disease patients at high risk and requiring shielding during the COVID19 pandemic. Clin Med (London, England) 2020 doi: 10.7861/clinmed.2020-0160. - DOI - PMC - PubMed
-
- Public Health England. (2020) Guidance on shielding and protecting people defined on medical grounds as extremely vulnerable from COVID-19. Available from: https://www.gov.uk/government/publications/guidance-on-shielding-and-pro.... Accessed 25 May 2020.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
